Article
When it comes to deciding the type of treatment a man with prostate cancer receives, his age often takes precedence over life expectancy, according to a study from the University Health Network in Toronto.
FDA approves integrated sacral neuromodulation system for urinary urge incontinence
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
Ultrasound imaging system now available to guide nonsurgical urology procedures
CPT 49186 vs 38780: Coding retroperitoneal mass excision